All Stories

  1. Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness

    Article • Platelets, May 2014, Taylor & Francis

    Dr Miguel Lozano

  2. Apheresis activity in Spain: A survey of the Spanish Apheresis Group

    Article • Transfusion and Apheresis Science, December 2013, Elsevier

    Dr Miguel Lozano

  3. Pathogen inactivation

    Article • Current Opinion in Hematology, November 2013, Wolters Kluwer Health

    Dr Miguel Lozano

  4. Plasma Treated with Methylene Blue and Light: Clinical Efficacy and Safety Profile

    Article • Transfusion Medicine Reviews, October 2013, Elsevier

    Dr Miguel Lozano

  5. The addition of MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2013, De Gruyter

    Dr Miguel Lozano

  6. Fatal Immune Hemolytic Anemia Following Allogeneic Stem Cell Transplantation: Report of 2 Cases and Review of Literature

    Article • Transfusion Medicine Reviews, July 2013, Elsevier

    Dr Miguel Lozano

  7. DEHP plasticizer and blood bags: challenges ahead

    Article • ISBT Science Series, May 2013, Wiley

    Dr Miguel Lozano

  8. Automated preparation of whole blood–derived platelets suspended in two different platelet additive solutions and stored for 7 days

    Article • Transfusion, May 2013, Wiley

    Dr Miguel Lozano

  9. Factors affecting red blood cell storage age at the time of transfusion

    Article • Transfusion, April 2013, Wiley

    Dr Miguel Lozano

  10. Haptoglobin is present in albumin used as a replacement solution for plasma exchange

    Article • Transfusion, July 2012, Wiley

    Dr Miguel Lozano

  11. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: Report of 31 cases and review of the literature

    Article • Autoimmunity Reviews, September 2011, Elsevier

    Dr Miguel Lozano

  12. Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges

    Article • Transfusion, May 2011, Wiley

    Dr Miguel Lozano

  13. Crítica de libros

    Article • Cirugía Española, April 2011, Elsevier

    Dr Miguel Lozano

  14. Platelet transfusions from D+ donors to D− patients: a 10‐year follow‐up study of 1014 patients

    Article • Transfusion, December 2010, Wiley

    Dr Miguel Lozano

  15. Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function

    Article • Transfusion, October 2010, Wiley

    Dr Miguel Lozano, Professor Raymond Goodrich

  16. Practices associated with ABO‐incompatible platelet transfusions: a BEST Collaborative international survey

    Article • Transfusion, August 2010, Wiley

    Dr Miguel Lozano

  17. Respuesta

    Article • Medicina Clínica, October 2009, Elsevier

    Dr Miguel Lozano

  18. Reducción de la tasa de protrombina causada por la administración de N-acetilcisteína en el tratamiento de la intoxicación por Amanita phalloides

    Article • Medicina Clínica, November 2008, Elsevier

    Dr Miguel Lozano

  19. Faculty Opinions recommendation of Galactosylation does not prevent the rapid clearance of long-term, 4 degrees C-stored platelets.

    Article • April 2008, F1000Research

    Dr Miguel Lozano

  20. Leukoreduced buffy coat–derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions

    Article • Transfusion, March 2007, Wiley

    Dr Miguel Lozano

  21. Tiempo de tromboplastina parcial activado, que no activada

    Article • Medicina Clínica, March 2007, Elsevier

    Dr Miguel Lozano

  22. Lower or higher doses for prophylactic platelet transfusions: results of a meta‐analysis of randomized controlled trials

    Article • Transfusion, February 2007, Wiley

    Dr Miguel Lozano

  23. Frederic Duran-Jorda: A Transfusion Medicine Pioneer

    Article • Transfusion Medicine Reviews, January 2007, Elsevier

    Dr Miguel Lozano

  24. Anti‐D alloimmunization after D‐mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases

    Article • Transfusion, December 2005, Wiley

    Dr Miguel Lozano

  25. Platelet transfusion in thrombotic thrombocytopenic purpura: between Scylla and Charybdis

    Article • Transfusion, November 2005, Wiley

    Dr Miguel Lozano

  26. Guía sobre la transfusión de componentes sanguíneos

    Article • Medicina Clínica, September 2005, Elsevier

    Dr Miguel Lozano

  27. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta‐analysis of randomized controlled trials

    Article • Transfusion, July 2005, Wiley

    Dr Miguel Lozano

  28. Stored platelets contain residual amounts of tissue factor: evidence from studies on platelet concentrates stored for prolonged periods

    Article • Transfusion, April 2005, Wiley

    Dr Miguel Lozano

  29. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib

    Article • Platelets, January 2005, Taylor & Francis

    Dr Miguel Lozano

  30. Hemostatic effect of activated recombinant factor VIIa in Bernard‐Soulier syndrome: studies in an in vitro model

    Article • Transfusion, December 2004, Wiley

    Dr Miguel Lozano

  31. Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma

    Article • Transfusion, February 2004, Wiley

    Dr Miguel Lozano

  32. ¿Plasmaféresis? Probablemente quiere decir un recambio plasmático

    Article • Medicina Clínica, September 2003, Elsevier

    Dr Miguel Lozano

  33. Importance of language

    Article • The Lancet, May 2003, Elsevier

    Dr Miguel Lozano

  34. ¿Plasmaféresis? Probablemente quiere decir un recambio plasmático

    Article • Medicina Clínica, January 2003, Elsevier

    Dr Miguel Lozano

  35. Glycoproteins expression on platelet membrane in inherited macrothrombocytopenias

    Article • Thrombosis Research, January 2003, Elsevier

    Dr Miguel Lozano

  36. The mesenchymal stem cell revealed

    Article • Transfusion, January 2003, Wiley

    Dr Miguel Lozano

  37. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility

    Article • Transfusion Medicine Reviews, January 2003, Elsevier

    Dr Miguel Lozano

  38. TRALI associated with HLA class II antibodies

    Article • Transfusion, August 2002, Wiley

    Dr Miguel Lozano

  39. Complicaciones no infecciosas graves de la transfusión

    Article • Medicina Clínica, January 2002, Elsevier

    Dr Miguel Lozano

  40. Platelet Procoagulant Activity Induced In Vivo by Muromonab-CD3 Infusion in Uremic Patients

    Article • Thrombosis Research, December 2001, Elsevier

    Dr Miguel Lozano

  41. Platelet Therapy. Current Status and Future Trends

    Article • Transfusion, December 2001, Wiley

    Dr Miguel Lozano

  42. Transfusion of incompatible RBCs to a patient with alloanti‐Kpb

    Article • Transfusion, May 2001, Wiley

    Dr Miguel Lozano

  43. Soporte hepático bioartificial en la insuficiencia hepática aguda grave. Primer caso tratado en España

    Article • Medicina Clínica, January 2001, Elsevier

    Dr Miguel Lozano

  44. Studies on the megakaryocytes of a patient with the Bernard‐Soulier syndrome

    Article • British Journal of Haematology, December 1990, Wiley

    Dr Miguel Lozano

  45. Adult T-cell Leukemia in a Chilean Resident in Spain: Long-Lasting Remission after 2-Deoxycoformycin Treatment

    Article • Leukemia & Lymphoma, January 1989, Taylor & Francis

    Dr Miguel Lozano